EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 30 January 2020

Nathalie Moll, EFPIA Director General, explores Europe’s shared goals and shared responsibilities in healthcare

New publication on Health Europa

In this article, released on 29 January on Health Europa, Nathalie Moll addresses how EFPIA intends to meet the challenge set out in the EU President's Mission letter to Stella Kyriakides, the new Health Commissioner.

"Broadly speaking, that means novel, flexible and collaborative models to solve issues of access to and shortages of medicines. It means supporting a stable, predictable regulatory environment with strong incentives to drive research into the next generation of treatments; and the adoption of a renewed industrial strategy for Europe to ensure the industry remains an innovator and world leader", declares Nathalie Moll. Read more

ECRD 2020: Few days left to submit your posters!

Are you conducting research on rare diseases or public health projects?
Don't miss the chance to showcase your work at #ECRD2020
Submit your poster abstract by 10 February.

10th European Conference on Rare Diseases & Orphan Products
14 May 2020

The upcoming ECRD 2020 will be held 100% online! Read more

Blogs

Everyday counts: 9 reasons why patients wait longer to get access to new cancer medicines
24 January 2020 - Minxian Congé - Professor Frederik Vernimmen

Working together to jointly identify factors which cause access delays, and co-create solutions that could accelerate... Read more

Events

Towards outcomes-based healthcare in Europe
04 February 2020 (Brussels)

The EU Health Coalition seeks to explore how the State of Health in the EU can help address current health systems challenges... Read more

Science, Technology and Regulations Coming Together for Better Patients’ Health
10 February 2020 (Amsterdam)

The primary objective of the Conference is to ensure that all attendees are brought fully up to date with the current... Read more

Joint MEB/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing
15 June 2020 (Virtual Live Training Course)

Join this training to discover the latest news on the international harmonisation and standardisation activities in... Read more

What we are reading

R&D plans are the stars in new EU industrial strategy
On 28 January 2020 (Science Business)

A draft plan, for adoption in Brussels on 4 March, highlights the importance of research and innovation in making EU... Read more

Identifying potential antibiotic leads is painfully slow, but these researchers identified...
On 28 January 2020 (IMI)

ENABLE surpassed their goal of identifying 3 leads for new antibiotics. With several more compounds in the pipeline,... Read more

EMA celebrates 25 years advancing public and animal health
On 27 January 2020 (EMA)

This week marks EMA’s 25th anniversary. Despite the environmental changes in which EMA operates, its mission has remained:... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu